Shay Capital’s Pfizer PFE Stock Holding History

Shay Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-20,000	Closed	-$1.05M	–	460
2022 Q2	$1.05M	Buy	+20,000	New	+$1.02M	0.21%	109

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Shay Capital's PFE Position: Q4 2023 in Review

Shay Capital sold out of Pfizer (PFE) in Q4 2023, closing a stake of 68,000 shares — an estimated $2.26M sold.

Shay Capital first reported a position in PFE in Q1 2021 and held it in 6 quarters. The position peaked at $2.26M in Q3 2023. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

Shay Capital reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
Shay Capital sold 68,000 Pfizer shares in Q4 2023, an estimated $2.26M.
Shay Capital first reported a position in Pfizer in Q1 2021 and held it in 6 quarters.
Shay Capital's Pfizer position peaked at $2.26M in Q3 2023.
2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Shay Capital's 13F filing for Q4 2023, filed 14 Feb 2024.